71 related articles for article (PubMed ID: 17512500)
21. The orphan nuclear receptor Rev-erbalpha: a transcriptional link between circadian rhythmicity and cardiometabolic disease.
Fontaine C; Staels B
Curr Opin Lipidol; 2007 Apr; 18(2):141-6. PubMed ID: 17353661
[TBL] [Abstract][Full Text] [Related]
22. Non-photic phase shifting of the circadian clock: role of the extracellular signal-responsive kinases I/II/mitogen-activated protein kinase pathway.
Antle MC; Tse F; Koke SJ; Sterniczuk R; Hagel K
Eur J Neurosci; 2008 Dec; 28(12):2511-8. PubMed ID: 19087176
[TBL] [Abstract][Full Text] [Related]
23. Obesity alters circadian expressions of molecular clock genes in the brainstem.
Kaneko K; Yamada T; Tsukita S; Takahashi K; Ishigaki Y; Oka Y; Katagiri H
Brain Res; 2009 Mar; 1263():58-68. PubMed ID: 19401184
[TBL] [Abstract][Full Text] [Related]
24. Dominant role of GABAB2 and Gbetagamma for GABAB receptor-mediated-ERK1/2/CREB pathway in cerebellar neurons.
Tu H; Rondard P; Xu C; Bertaso F; Cao F; Zhang X; Pin JP; Liu J
Cell Signal; 2007 Sep; 19(9):1996-2002. PubMed ID: 17582742
[TBL] [Abstract][Full Text] [Related]
25. An altered fibronectin matrix induces anoikis of human squamous cell carcinoma cells by suppressing integrin alpha v levels and phosphorylation of FAK and ERK.
Kamarajan P; Kapila YL
Apoptosis; 2007 Dec; 12(12):2221-31. PubMed ID: 17879163
[TBL] [Abstract][Full Text] [Related]
26. Retinoic acid receptor-related orphan receptor alpha as a therapeutic target in the treatment of dyslipidemia and atherosclerosis.
Jakel H; Fruchart-Najib J; Fruchart JC
Drug News Perspect; 2006 Mar; 19(2):91-7. PubMed ID: 16628264
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional regulation of apolipoprotein A5 gene expression by the nuclear receptor RORalpha.
Genoux A; Dehondt H; Helleboid-Chapman A; Duhem C; Hum DW; Martin G; Pennacchio LA; Staels B; Fruchart-Najib J; Fruchart JC
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1186-92. PubMed ID: 15790933
[TBL] [Abstract][Full Text] [Related]
28. C-terminal hemocyanin from hemocytes of Penaeus vannamei interacts with ERK1/2 and undergoes serine phosphorylation.
Havanapan PO; Kanlaya R; Bourchookarn A; Krittanai C; Thongboonkerd V
J Proteome Res; 2009 May; 8(5):2476-83. PubMed ID: 19284748
[TBL] [Abstract][Full Text] [Related]
29. The C-terminal domain of Mnk1a plays a dual role in tightly regulating its activity.
Goto S; Yao Z; Proud CG
Biochem J; 2009 Sep; 423(2):279-90. PubMed ID: 19650764
[TBL] [Abstract][Full Text] [Related]
30. Betagamma subunits of G(i/o) suppress EGF-induced ERK5 phosphorylation, whereas ERK1/2 phosphorylation is enhanced.
Obara Y; Okano Y; Ono S; Yamauchi A; Hoshino T; Kurose H; Nakahata N
Cell Signal; 2008 Jul; 20(7):1275-83. PubMed ID: 18407464
[TBL] [Abstract][Full Text] [Related]
31. Extracellular signal-regulated kinases (ERK) and protein kinase C (PKC) activities are involved in the modulation of Nur77 and Nor-1 expression by dopaminergic drugs.
Bourhis E; Maheux J; Rouillard C; Lévesque D
J Neurochem; 2008 Jul; 106(2):875-88. PubMed ID: 18466322
[TBL] [Abstract][Full Text] [Related]
32. Nurr1 is phosphorylated by ERK2 in vitro and its phosphorylation upregulates tyrosine hydroxylase expression in SH-SY5Y cells.
Zhang T; Jia N; Fei E; Wang P; Liao Z; Ding L; Yan M; Nukina N; Zhou J; Wang G
Neurosci Lett; 2007 Aug; 423(2):118-22. PubMed ID: 17681692
[TBL] [Abstract][Full Text] [Related]
33. The cooked meat carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine activates the extracellular signal regulated kinase mitogen-activated protein kinase pathway.
Creton SK; Zhu H; Gooderham NJ
Cancer Res; 2007 Dec; 67(23):11455-62. PubMed ID: 18056474
[TBL] [Abstract][Full Text] [Related]
34. RORalpha-mediated Purkinje cell development determines disease severity in adult SCA1 mice.
Serra HG; Duvick L; Zu T; Carlson K; Stevens S; Jorgensen N; Lysholm A; Burright E; Zoghbi HY; Clark HB; Andresen JM; Orr HT
Cell; 2006 Nov; 127(4):697-708. PubMed ID: 17110330
[TBL] [Abstract][Full Text] [Related]
35. Neurodegeneration: a case of arrested development?
La Spada AR
Cell; 2006 Nov; 127(4):669-71. PubMed ID: 17110325
[TBL] [Abstract][Full Text] [Related]
36. Expression and regulation of the nuclear receptor RORalpha in human vascular cells.
Besnard S; Heymes C; Merval R; Rodriguez M; Galizzi JP; Boutin JA; Mariani J; Tedgui A
FEBS Lett; 2002 Jan; 511(1-3):36-40. PubMed ID: 11821045
[TBL] [Abstract][Full Text] [Related]
37. ROR alpha in genetic control of cerebellum development: 50 staggering years.
Gold DA; Gent PM; Hamilton BA
Brain Res; 2007 Apr; 1140():19-25. PubMed ID: 16427031
[TBL] [Abstract][Full Text] [Related]
38. Isoform-specific inhibition of ROR alpha-mediated transcriptional activation by human FOXP3.
Du J; Huang C; Zhou B; Ziegler SF
J Immunol; 2008 Apr; 180(7):4785-92. PubMed ID: 18354202
[TBL] [Abstract][Full Text] [Related]
39. RORalpha: an orphan nuclear receptor on a high-cholesterol diet.
Willson TM
Structure; 2002 Dec; 10(12):1605-6. PubMed ID: 12467566
[TBL] [Abstract][Full Text] [Related]
40. Crystal structure of the human RORalpha Ligand binding domain in complex with cholesterol sulfate at 2.2 A.
Kallen J; Schlaeppi JM; Bitsch F; Delhon I; Fournier B
J Biol Chem; 2004 Apr; 279(14):14033-8. PubMed ID: 14722075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
